Tibolone Up-Regulates the Mrna Expression of Osteoprotegerin in Bone Tissue of Ovariectomized Rats

商敏,杨欣,李亚珍,吴琼,顾蓓,廖秦平
DOI: https://doi.org/10.3969/j.issn.1004-7379.2006.10.010
2006-01-01
Abstract:Objective:To build a postmenopausal osteoporotic model in rats and investigate the effect of tibolone on the expression of OPG mRNA in lumbar vertebra of ovariectomized rats,and to analyze its mechanism in the prevention of postmenopausal osteoporosis.Methods: Forty female rats at 6 months of age were randomly allocated into 4 groups:sham operated group,ovariectomized group,ovariectomized +valerate estradiol group,and ovariectomized +tibolone group.They were sacrificed after lavaged for 13 weeks.The fourth lumbar vertebra was dissected out for histomorphology and the second lumbar vertebra for measurement of mRNA level of OPG by way of reverse transcription polymerase chain reaction technique.Results:The trabecular volume was significantly lower in OVX group rats than in SHAM group rats,while ostoid seam was significantly higher,valerate estradiol and tibolone can increase the trabecular volume and reduced ostoid seam significantly in OVX rats.To compare with SHAM rats,the mRNA level of OPG decreased significantly in OVX rats,valerate estrodiol,and tibolone can up-regulate the expression level of OPG mRNA significantly.Conclusion:Our experiment built the postmenopausal osteoporotic model successfully.Valerate estradiol and tibolone can prevent postmenopausal osteoporosis by its inhibitory effect on bone turnover.OVX-induced bone loss is associated with OPG.Tibolone,just like valerate estradiol,perhaps has its anti-resorbtive effect on bone by the signal of OPG.
What problem does this paper attempt to address?